<DOC>
	<DOCNO>NCT01677026</DOCNO>
	<brief_summary>The primary objective Registry : 1 . Monitor transfer ATI Neurostimulation System safety/clinical performance large number center post market phase 2 . Collect additional evidence support reimbursement clinical acceptance long term follow</brief_summary>
	<brief_title>Data Collection ATI Neurostimulation System : SPG Stimulation Cluster Headache</brief_title>
	<detailed_description />
	<mesh_term>Headache</mesh_term>
	<mesh_term>Cluster Headache</mesh_term>
	<criteria>Subject meet CE mark label cluster headache . Subject 's typical cluster headache bout last minimum 16 week , opinion Investigator . Subject agree maintain current preventive headache medication regimen ( change type , frequency dose except manage tolerability ) Study Enrollment completion Therapy Evaluation Period . Subject ability read , comprehend reliably record information require Protocol . Subject able provide write informed consent prior participation study . Subject change type , dosage frequency take preventive headache medication &lt; one ( 1 ) month prior Study Enrollment . Per CE mark labeling : In opinion Investigator , subject bony facial deformity , inappropriate surgical anatomy facial surgery surgical area side plan surgery would prevent proper placement ATI Neurostimulator . Subject significant pain problem might confound study assessment opinion Investigator .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>